Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2023 2
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial.
Faber RA, Meijer RPJ, Droogh DHM, Jongbloed JJ, Bijlstra OD, Boersma F, Braak JPBM, Meershoek-Klein Kranenbarg E, Putter H, Holman FA, Mieog JSD, Neijenhuis PA, van Staveren E, Bloemen JG, Burger JWA, Aukema TS, Brouwers MAM, Marinelli AWKS, Westerterp M, Doornebosch PG, van der Weijde A, Bosscha K, Handgraaf HJM, Consten ECJ, Sikkenk DJ, Burggraaf J, Keereweer S, van der Vorst JR, Hutteman M, Peeters KCMJ, Vahrmeijer AL, Hilling DE. Faber RA, et al. Among authors: droogh dhm. Lancet Gastroenterol Hepatol. 2024 Oct;9(10):924-934. doi: 10.1016/S2468-1253(24)00198-5. Epub 2024 Aug 13. Lancet Gastroenterol Hepatol. 2024. PMID: 39151436 Clinical Trial.
Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple resection (SPARROW): a study protocol for a multicentre, open-label, randomised controlled trial.
Droogh DHM, de Boer MGJ, van Prehn J, Putter H, Bonsing BA, Bosscha K, Bouwense SAW, Braak JPBM, Hoogwater FJH, Lips DJ, Luyer MDP, Stommel MWJ, Wijsman JH, Besselink MG, van Santvoort HC, Koerkamp BG, Vahrmeijer AL, Mieog JSD; Dutch Pancreatic Cancer Group. Droogh DHM, et al. Trials. 2025 Mar 13;26(1):88. doi: 10.1186/s13063-024-08574-z. Trials. 2025. PMID: 40083036 Free PMC article.
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial.
Dekker EN, Theijse RT, van Dam JL, Janssen QP, Stoop TF, Bonsing BA, Bosscha KP, Bouwense SAW, Busch OR, Coene PLO, van Eijck CHJ, van Her Harst E, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, Liem MSL, Mieog JSD, Nieuwenhuijs VB, Patijn GA, van Santvoort HC, Schreinemakers JMJ, de Wilde RF, Wit F, Zonderhuis BM, Homs MYV, van Tienhoven G, Wilmink JW, Besselink MG, Koerkamp BG; Dutch Pancreatic Cancer Group. Dekker EN, et al. Ann Surg. 2025 Aug 12. doi: 10.1097/SLA.0000000000006910. Online ahead of print. Ann Surg. 2025. PMID: 40792645
Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms.
de Graaf N, Emmen AMLH, Ramera M, van Hilst J, Björnsson B, Boggi U, Bruna CL, Busch OR, Daams F, Droogh DHM, Ferrari G, Festen S, Guerra M, de Hingh I, Keck T, Groot Koerkamp B, Lips DJ, Luyer MDP, Mieog JSD, Morelli L, Molenaar IQ, de Wilde RF, Ali M, Ferrari C, Berkhof J, Maisonneuve P, Abu Hilal M, Besselink MG. de Graaf N, et al. Among authors: droogh dhm. NEJM Evid. 2025 Dec;4(12):EVIDoa2500045. doi: 10.1056/EVIDoa2500045. Epub 2025 Nov 25. NEJM Evid. 2025. PMID: 41288428 Clinical Trial.
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trials.
Strijbos BTM, Kraakman I, Hopstaken JS, van Dongen JC, Janssen QP, van Dam JL, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Bos H, Bosscha KP, Buijsen J, Busch OR, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groothuis K, Haberkorn BCM, de Hingh IHJT, van der Holt B, Homs MYV, van Hooft JE, Karsten TM, Kerver ED, van der Kolk MB, van Laarhoven CJHM, Liem MSL, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, van Santvoort HC, Streppel MM, Suker M, Versteijne E, Vissers PAJ, de Vos-Geelen J, Wilmink JW, Zwinderman AH, van Eijck CHJ, van Tienhoven G, Groot Koerkamp B, Stommel MWJ; Dutch Pancreatic Cancer Group. Strijbos BTM, et al. Br J Surg. 2025 Nov 29;112(12):znaf261. doi: 10.1093/bjs/znaf261. Br J Surg. 2025. PMID: 41324552 No abstract available.